U.S. senator asks for CFIUS review of GNC purchase by Chinese company
Reuters
Published Sep 10, 2020 02:27PM ET
Updated Sep 10, 2020 03:15PM ET
WASHINGTON (Reuters) - U.S. Senator Marco Rubio, a Republican and a China hawk, asked for a national security review of plans by General Nutrition Centers (N:GNC), or GNC, to sell itself to Harbin Pharmaceutical Group Co Ltd.
Rubio, who had also urged a probe of TikTok's ownership by another Chinese firm, made the request in a letter to Treasury Secretary Steven Mnuchin. The department leads the inter-agency Committee on Foreign Investment in the United States.
GNC, a health and nutrition products retailer, has said it has agreed in principle with many lenders to sell itself to an affiliate of its largest shareholder, Harbin Pharmaceutical (SS:600664), for $760 million in a court-supervised auction, subject to higher bids.
Harbin's controlling stake was reviewed by CFIUS and approved in 2018, a GNC spokesperson said, adding that no consumer data was available to any foreign national.
"That (2018) transaction was approved, and no facts or circumstances have changed to call the committee’s support into question. We will continue to work with all relevant agencies throughout the restructuring process and maintain our rigorous standards for data privacy," the spokesperson said.
In his letter, Rubio said that the Chinese government is seeking sensitive data about Americans through a variety of means, and that GNC data would be valuable.
"Efforts to obtain personal and sensitive data related to health information and financial transactions of U.S. persons must be reviewed with an understanding of the malign foreign policy and intelligence aims of the Chinese government and Communist Party," he wrote.
Rubin also noted that GNC has many shops in and near U.S. military facilities. "In the event of a GNC acquisition by HPGC, Chinese authorities and intelligence officials could leverage GNC military sites to gain access to those restricted locations," he wrote.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.